| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189739 | Brachytherapy | 2013 | 11 Pages |
Abstract
Total dose delivery and dose distributions for both 142Pr and 90Y within tumors and blood vessels were obtained and compared. Shorter half-life of 142Pr is an advantage, enabling a faster dose delivery. The higher BED found for 142Pr implies potential improvement in the treatment effectiveness. 142Pr showed to be an attractive option for applications in microsphere brachytherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Maria Clara M. Ferreira, Tarun K. Podder, Karl H. Rasmussen, Jae W. Jung,